Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Lupin Limited
Press Release Jul 04 2023
Business
Jul 4 2023
4 min read

Press Release Jul 04 2023

Lupin Limited has informed the Exchange regarding a press release dated July 04, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Dolutegravir Tablets for OralSuspension.".

View Attachment